Rongguo Wei
AlsetAbout Rongguo Wei
Rongguo Wei is Co-Chief Financial Officer (Co-CFO) of Alset Inc. (AEI), serving since March 2018. He is 54 and a certified public accountant with an MBA (University of Maryland), a Master of Business Taxation (University of Minnesota), a Master in Business (Tsinghua University), and a Bachelor’s (Beihang University) . His remit spans finance, accounting, reporting and taxation across AEI and affiliates, including CFO roles at Winning Catering Group, Inc. (since March 2017) and HWH International Inc. (since October 2021) . Company performance over 2022–2024 shows revenue growth from 2022 to 2023 then a pullback in 2024, while EBITDA remained negative; see table below (values with asterisks indicate S&P Global sourced) .
AEI Financial Performance During Recent Years
| Metric | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|
| Revenues (USD) | $3,842,279* | $20,976,419 | $19,608,184 |
| EBITDA (USD) | -$6,126,297* | -$799,785* | -$1,270,020* |
Values with asterisks are retrieved from S&P Global.
Past Roles
| Organization | Role | Years | Strategic impact / responsibilities |
|---|---|---|---|
| Alset Inc. | Co-Chief Financial Officer | Mar 2018–present | Executive finance leadership for AEI; executive officer signature on multiple 8-Ks evidencing active role . |
| SeD Development Management LLC | CFO | Aug 2016–present (as stated in bio) | Oversight of all finance, accounting, reporting, and taxation activities . |
| Winning Catering Group, Inc. (formerly LiquidValue Development Inc.) | CFO | Mar 2017–present | Finance leadership for affiliate entity . |
| HWH International Inc. | CFO | Oct 2021–present | CFO of Nasdaq-listed affiliate following business combination . |
External Roles
| Organization | Role | Years | Notes |
|---|---|---|---|
| Amarantus Bioscience Holdings, Inc. | Director | Feb 2017–May 2017 | Short stint on board prior to CFO role . |
| Amarantus Bioscience Holdings, Inc. | CFO | Feb 2017–Nov 2017 | Finance leadership at biotech firm . |
| American Silk Mill, LLC | Controller | Aug 2014–Jul 2016 | Textile manufacturing and distribution . |
| Air Products & Chemicals, Inc. | Senior Financial Analyst | Jan 2013–Jun 2014 | Corporate finance role at industrials company . |
| First Quality Enterprises, Inc. | Financial/Accounting Analyst | 2011–2012 | Personal products company . |
| Hong Yuan Securities (Beijing) | Equity Analyst | Pre-US career | Industrial and public company research . |
Fixed Compensation
| Year | Base salary (USD) | Cash bonus (USD) | Source |
|---|---|---|---|
| 2024 | $232,073 | — | |
| 2023 | $176,517 | — | |
| 2022 | $156,184 | — | |
| 2021 | $136,184 | $86,092 |
Notes: Summary Compensation Tables show no stock awards, option awards, or non-equity incentive plan compensation for Mr. Wei in 2023–2024 .
Performance Compensation
| Incentive type | Metric(s) | Weighting | Target | Actual/Payout | Vesting |
|---|---|---|---|---|---|
| Annual cash incentive | Not disclosed for Co-CFO | — | — | No non-equity incentive reported for 2023–2024 | — |
| RSUs/PSUs | Not disclosed for Co-CFO | — | — | No stock awards reported for 2023–2024 | — |
| Stock options | N/A | — | — | Company disclosed no options or equity awards to NEOs in 2024 | — |
Additional context:
- AEI replaced its 2018 plan with a 2025 Incentive Compensation Plan effective Mar 17, 2025 (covers options and restricted awards), but no awards to Mr. Wei are disclosed in 2024 .
Equity Ownership & Alignment
| Item | Detail |
|---|---|
| Total beneficial ownership | 0 shares; 0.0% of outstanding (as of Oct 22, 2025) . |
| Options (exercisable/unexercisable) | None; company notes directors and officers do not hold stock options or warrants at present . |
| Vested vs unvested equity | No equity awards disclosed for Mr. Wei in 2024 . |
| Shares pledged as collateral | None disclosed; insider trading policy adopted Mar 19, 2025; policy also bars short sales for Section 16 persons . |
| Ownership guidelines | Not disclosed. |
Implication: With no AEI share ownership and no disclosed equity awards, Mr. Wei’s direct pay-for-performance alignment via AEI equity is limited as of the latest proxy .
Employment Terms
| Term | Disclosure |
|---|---|
| Start date / tenure | Co-CFO since March 2018 . |
| Employment agreement | None specific to Mr. Wei is disclosed; CEO/Co-CEO agreements are disclosed separately . |
| Severance / Change-of-control | Not disclosed for Mr. Wei; CEO has change-of-control/severance provisions (context) . |
| Clawback | Not specifically disclosed; no executive-specific clawback terms for Mr. Wei referenced. |
| Indemnification | Company intends to enter indemnification agreements with all directors and executive officers . |
| Non-compete / Non-solicit | Not disclosed for Mr. Wei. |
Investment Implications
- Compensation alignment: Mr. Wei’s compensation is predominantly fixed cash with no disclosed annual performance bonus payouts in 2023–2024 and no equity awards, limiting pay sensitivity to AEI financial or stock outcomes . This lowers incentive-driven volatility but also reduces direct shareholder alignment.
- Ownership/retention risk: With 0 AEI shares and no options outstanding, insider selling pressure from Mr. Wei is negligible; retention levers appear mainly cash-based, and no severance/CIC protections for him are disclosed (contrast with CEO), which could imply retention risk in a stressed scenario .
- Governance backdrop: AEI is tightly controlled by its CEO (90.3% ownership), and related-party transactions are significant; while not directly tied to Mr. Wei, this framework concentrates decision power and may shape finance priorities he executes .
- Company performance context: Revenues rose sharply from 2022 to 2023 and softened in 2024; EBITDA remained negative, indicating ongoing profitability challenges during recent years of his tenure .
- Risk indicators: Company disclosed no material legal proceedings, but identified material weaknesses in internal controls—an area within the CFO purview to help remediate .
Overall, Mr. Wei is a seasoned finance operator with deep affiliate experience and strong technical credentials, but his AEI-specific equity alignment is minimal and incentive disclosure is sparse. Investors should focus on AEI’s progression on internal control remediation and profitability, and watch for any future equity grants or revised incentive metrics under the 2025 plan to improve alignment .